[Vomiting accompanying cytostatic treatment, and its control].
D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D013759:Dronabinol / Q000627:therapeutic use; D004341:Drug Evaluation; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008787:Metoclopramide / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy; D011346:Prochlorperazine / Q000627:therapeutic use; D014839:Vomiting / Q000139:chemically induced* / Q000517:prevention & control
D000932:Antiemetics; D000970:Antineoplastic Agents; D006634:Histamine H1 Antagonists; D013759:Dronabinol; D008787:Metoclopramide; D011346:Prochlorperazine
Wymioty towarzyszace leczeniu cytostatycznemu i ich zwalczanie.